News tagged ‘ChildhoodCancer’ clear
- Stuart H. Orkin, MD, chairman of the department of pediatric oncology at Dana-Farber/Children’s Hospital Cancer Center, will receive the Jessie Stevenson Kovalenko Medal at the National Academy of Sciences’ 150th Annual meeting in April.
Tags: ChildhoodCancer, Honors
- Almost two-thirds of children who receive stem cell transplants are readmitted to the hospital within six months, according to researchers at Dana-Farber/Children’s Hospital Cancer Center in Boston.
Tags: ChildhoodCancer, StemCellTransplant
- Dana-Farber/Children's Hospital Cancer Center researchers have linked genetic mutations to each of the four recognized subtypes of medulloblastoma, the most common malignant brain tumor of children.
Tags: BasicResearch, ChildhoodCancer, Genomics, BrainTumors
- Justin Bieber's date with young brain tumor patient Avalanna Routh has focused attention on atypical teratoid rhabdoid tumor, or AT/RT. Mark Kieran, MD, PhD, of Dana-Farber/Children's Hospital Cancer Center, discusses this rare cancer.
Tags: ChildhoodCancer, BrainTumors
- Pediatric patients with B-precursor acute lymphoblastic leukemia who are likely to relapse after chemotherapy treatment can reduce those odds by receiving additional courses of chemotherapy, according to research by Dana-Farber/Children's Hospital Cancer Center investigators.
Tags: chemotherapy, ChildhoodCancer, Leukemia
- An irregularity within many neuroblastoma cells may indicate whether the tumor is vulnerable to a new class of anti-cancer drugs known as BET bromodomain inhibitors.
- Physicians who inform parents of children with cancer about the likely
course of the disease can provide hope, even when the child's prognosis
is poor, according to a Dana-Farber Cancer Institute study presented at a
press briefing at the American Society of Clinical Oncology annual
- Researchers at Dana-Farber and Children's Hospital Boston have shown that changes in the structure of DNA are responsible for hard-to-treat MLL leukemia – and that it's possible to reverse this process.
Tags: BasicResearch, ChildhoodCancer
- A national drug shortage has been linked to a higher rate of relapse among Hodgkin lymphoma patients enrolled in a national pediatric clinical trial, report researchers involved in the study.
Tags: chemotherapy, ChildhoodCancer, Lymphoma
Showing 11-20 of 30 items